• Tango Therapeutics to go public with $353m merger deal pharmaceutical-technology
    April 16, 2021
    Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special purpose acquisition company BCTG Acquisition worth up to a total of approximately $353m.
PharmaSources Customer Service